k Press conference on crowdfunding for regenerative medicine using iPS cells from right Shinya Yamanaka, President of the Kyoto University iPS Cell Research Foundation, Takatoshi Nishiwaki, Governor of Kyoto University, and Daisaku Kadokawa, Mayor of Kyoto City. From right Shinya Yamanaka, President of the Kyoto University iPS Cell Research Foundation, Governor Takatoshi Nishiwaki, and Kyoto Mayor Daisaku Kadokawa at a press conference announcing the opening of crowdfunding for the realization of regenerative medicine using iPS cells, October 28, 2020, in Shimogyoku, Kyoto City. Editorial Stock Photo - Afloimages
Sign up
Login
All images
Press conference on crowdfunding for regenerative medicine using iPS cells  from right  Shinya Yamanaka, President of the Kyoto University iPS Cell Research Foundation, Takatoshi Nishiwaki, Governor of Kyoto University, and Daisaku Kadokawa, Mayor of Kyoto City.  From right  Shinya Yamanaka, President of the Kyoto University iPS Cell Research Foundation, Governor Takatoshi Nishiwaki, and Kyoto Mayor Daisaku Kadokawa at a press conference announcing the opening of crowdfunding for the realization of regenerative medicine using iPS cells, October 28, 2020, in Shimogyo ku, Kyoto City.
ED

Press conference on crowdfunding for regenerative medicine using iPS cells (from right) Shinya Yamanaka, President of the Kyoto University iPS Cell Research Foundation, Takatoshi Nishiwaki, Governor of Kyoto University, and Daisaku Kadokawa, Mayor of Kyoto City.

(From right) Shinya Yamanaka, President of the Kyoto University iPS Cell Research Foundation, Governor Takatoshi Nishiwaki, and Kyoto Mayor Daisaku Kadokawa at a press conference announcing the opening of crowdfunding for the realization of regenerative medicine using iPS cells, October 28, 2020, in Shimogyo-ku, Kyoto City.

Details

ID
147292830

Collection

License type
Editorial

Restrictions
High-resolution file available on request
Authorization requested before purchase
Authorization requested before purchase

Creation date
30-10-2020

Contact Aflo for all commercial uses.


Sign in
Member access
Login not found.